Crossing borders with real-world evidence: lessons from the elacestrant caseReal-World EvidenceCase studyBreast cancerHTA and Market AccessLife sciencesHEOR / RWEReal-World Data
ISPOR 2026 reflections: AI, access, and the evolving role of RWE in oncologyReal-World EvidenceRegulatoryHTA and Market AccessArtificial intelligenceLife sciencesHEOR / RWEReal-World Data
Informing global evidence strategies with real-world data across multiple geographiesReal-World EvidenceRegulatoryHTA and Market AccessLife sciencesReal-World Data
